dm+d

109113000

Articles

Safety in Lactation: Drugs for urinary frequency, enuresis, and incontinence

25 September 2020This group of drugs have varied mechanisms of action in treating urinary control conditions. Indications are broadly similar for all drugs, although there are small…

Drugs for urinary disorders – are any lactose-free?

5 February 2020This Medicine Q&A gives details of available urinary frequency, enuresis, incontinence and urinary retention preparations that do not contain lactose. There is a lactose-free preparation…
Search Articles

Medicine Compliance Aid Stability

DetrusitolPfizer Ltd

Pfizer Ltd
Detrusitol
Tablets f/c 1mg, 2mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special precautions for storage
21 September 2015

Detrusitol XLPfizer Ltd

Pfizer Ltd
Detrusitol XL
Capsules m/r 4mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Store in original container (bottle) or box (blister strips)
21 September 2015

Lactation Safety Information

Oxybutynin
No published evidence of safety
Monitor infant for anticholinergic effects, e.g. urinary retention, colic and constipation
18 September 2020